Urine Ethyl Glucuronide Unraveling the Reality of Abstinence Monitoring in a Routine Outpatient Setting: A Cross-Sectional Comparison with Ethanol, Self Report and Clinical Judgment

被引:12
作者
Barrio, Pablo [1 ,3 ]
Teixidor, Lidia [1 ]
Rico, Naira [2 ]
Bruguera, Pol [1 ]
Ortega, Lluisa [1 ]
Luis Bedini, Jose [2 ]
Gual, Antoni [1 ,3 ]
机构
[1] Hosp Clin Barcelona, Clin Neurosci Inst, Addict Behav Unit, Villarroel 170, ES-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Dept Biochem, Barcelona, Spain
[3] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain
关键词
Alcohol; Ethyl glucuronide; Abstinence; Recent drinking; Monitorization; Relapse prevention; ALCOHOL-USE; EXTERNAL VALIDITY; PSYCHIATRIC-INPATIENTS; IMPROVE VERIFICATION; USE DISORDERS; SULFATE; TRIALS; CONSUMPTION; DRINKING; ETG;
D O I
10.1159/000445741
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims: To test the screening performance of urinary ethyl glucuronide (EtG) under routine clinical conditions in a sample of alcohol-dependent outpatients, comparing it against urinary ethanol, self reports and clinical judgment. Methods: A cross-sectional study under routine conditions was conducted in February 2015, where 613 consecutive urinary samples, provided by 188 outpatients with alcohol use disorders, were analyzed for ethanol and EtG (cut-off level = 500 ng/ml). Clinical variables such as the presence of aversive medication, comorbidities and clinician judgment were also collected. The discrepancy between the number of alcohol and EtG positives was recorded. A logistic regression analysis including clinical variables was conducted to assess for predictors of EtG positivity. Results: Urinary alcohol yielded 9 positives (1.5% of all urine samples) belonging to 8 patients. EtG yielded 136 positives (22% of all urine samples) belonging to 74 patients. Of these, 93.4% (127 of 136) were negative for alcohol. All urinary alcohol positives resulted in EtG positives. The clinician judged 48 samples from 26 patients as belonging to not abstinent patients and 550 samples from 178 patients as belonging to abstinent patients. She was unsure in 15 samples from 15 patients. When comparing it against EtG as the gold standard, the area under the curve was 0.592. Self reports were extremely unreliable in this study, with only 5 patients reporting drinking in a total of 6 urine samples. In the logistic regression model, only aversive medications (OR 2.1, 95% CI 1.3-3.3) and clinician judgment (OR 2, 95% CI 1.4-2.9) resulted in significant effects. Conclusions: EtG performed largely better than ethanol for urine screening in alcohol outpatients, detecting an extra 20.4% (125 out of 613) of positives. It means that for each alcohol-positive sample, there were 15 EtG-positive samples. Although better than ethanol, clinician judgment was also not performed efficiently. If routinely implemented in the screening of alcohol outpatients, EtG might bring relevant changes that merit further research. (c) 2016 S. Karger AG, Basel
引用
收藏
页码:243 / 248
页数:6
相关论文
共 38 条
  • [1] Evaluation of a new immunoassay for urinary ethyl glucuronide testing
    Boettcher, Michael
    Beck, Olof
    Helander, Anders
    [J]. ALCOHOL AND ALCOHOLISM, 2008, 43 (01): : 46 - 48
  • [2] Urinary Ethyl Glucuronide and Ethyl Sulfate Testing for Recent Drinking in Alcohol-Dependent Outpatients Treated with Acamprosate or Placebo
    Dahl, Helen
    Hammarberg, Anders
    Franck, Johan
    Helander, Anders
    [J]. ALCOHOL AND ALCOHOLISM, 2011, 46 (05): : 553 - 557
  • [3] Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients
    de Beaurepaire, Renaud
    Lukasiewicz, Michael
    Beauverie, Patrick
    Castera, Sophie
    Dagorne, Odile
    Espaze, Renaud
    Falissard, Bruno
    Giroult, Patrick
    Houery, Michele
    Mahuzier, Georges
    Matheron, Isabelle
    Niel, Philippe
    Padovani, Pierre
    Poisson, Nicole
    Richier, Jean-Paul
    Rocher, Jerome
    Ruetsh, Odile
    Touzeau, Didier
    Visinoni, Andre
    Molimard, Robert
    [J]. EUROPEAN PSYCHIATRY, 2007, 22 (08) : 540 - 548
  • [4] How to assess the external validity of therapeutic trials: a conceptual approach
    Dekkers, O. M.
    von Elm, E.
    Algra, A.
    Romijn, J. A.
    Vandenbroucke, J. P.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2010, 39 (01) : 89 - 94
  • [5] Use of Novel Technology-Based Techniques to Improve Alcohol-Related Outcomes in Clinical Trials
    Gurvich, Eugenia M.
    Kenna, George A.
    Leggio, Lorenzo
    [J]. ALCOHOL AND ALCOHOLISM, 2013, 48 (06): : 712 - 719
  • [6] Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake
    Halter, Claudia C.
    Dresen, Sebastian
    Auwaerter, Volker
    Wurst, Friedrich M.
    Weinmann, Wolfgang
    [J]. INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2008, 122 (02) : 123 - 128
  • [7] Monitoring of the Alcohol Biomarkers PEth, CDT and EtG/EtS in an Outpatient Treatment Setting
    Helander, Anders
    Peter, Oszkar
    Zheng, Yufang
    [J]. ALCOHOL AND ALCOHOLISM, 2012, 47 (05): : 552 - 557
  • [8] Detection Times for Urinary Ethyl Glucuronide and Ethyl Sulfate in Heavy Drinkers during Alcohol Detoxification
    Helander, Anders
    Bottcher, Michael
    Fehr, Christoph
    Dahmen, Norbert
    Beck, Olof
    [J]. ALCOHOL AND ALCOHOLISM, 2009, 44 (01): : 55 - 61
  • [9] Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings?
    Hoertel, Nicolas
    de Maricourt, Pierre
    Katz, Julien
    Doukhan, Raphael
    Lavaud, Pierre
    Peyre, Hugo
    Limosin, Frederic
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (06) : 697 - 703
  • [10] Clinical (Nonforensic) Application of Ethyl Glucuronide Measurement: Are We Ready?
    Jatlow, Peter
    O'Malley, Stephanie S.
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 968 - 975